logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produswest2
Showing 1 - 10 of 10 Items
Showing 1 - 10 of 10 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Conference Material
|
Abstract

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa causing an estimated 300 000 to 500 000 cases and 5 000 fataliti...
Conference Material
|
Video

Interim results of the multi-site incidence study of Lassa fever in West Africa

Camacho A
2023-06-08 • Epicentre Scientific Day Paris 2023
2023-06-08 • Epicentre Scientific Day Paris 2023
Conference Material
|
Video

Enquête sur le paludisme grave chez l’enfant au Bénin: Comprendre le retard dans sa prise en charge et proposer une stratégie de lutte pour réduire la mortalité infantile

Le Hesran JY
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Conference Material
|
Slide Presentation

Enquête sur le paludisme grave chez l’enfant au Bénin: Comprendre le retard dans sa prise en charge et proposer une stratégie de lutte pour réduire la mortalité infantile

Le Hesran JY, Hémadou A, Adamou R, Razack M, Tahar R,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Conference Material
|
Abstract

Delayed treatment of severe malaria in children in Benin and strategies for reducing malaria-related infant mortality

Le Hesran JY, Hémadou A, Adamou R, Razack M, Tahar R,  et al.
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
From 2000 to 2015, overall mortality from malaria halved. But since then, mortality rates have stagnated and even risen again in some African countries. It has been sugg...
Journal Article
|
Protocol

A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol

Penfold S, Adegnika AA, Asogun D, Ayodeji O, Azuogu BN,  et al.
2023-03-30 • PLOS One
2023-03-30 • PLOS One
BACKGROUND
Lassa fever (LF), a haemorrhagic illness caused by the Lassa fever virus (LASV), is endemic in West Africa and causes 5000 fatalities every year. The true prevalence and i...
Journal Article
|
Research

Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis

Zheng Q, Luquero FJ, Ciglenecki I, Wamala JF, Abubakar A,  et al.
2022-09-01 • International Journal of Infectious Diseases
2022-09-01 • International Journal of Infectious Diseases
BACKGROUND
Cholera remains a public health threat but is inequitably distributed across sub-Saharan Africa. Lack of standardized reporting and inconsistent outbreak definitions limit...
Journal Article
|
Research

The burden and outcomes of childhood tuberculosis in Cotonou, Benin

Ade S, Harries AD, Trebucq A, Hinderaker SG, Ade G,  et al.
2013-03-21 • Public Health Action
2013-03-21 • Public Health Action
SETTING
The National Tuberculosis Programme (NTP) and the paediatric ward of the General Hospital (GH), Cotonou, Benin.

OBJECTIVE
To describe the burden of tuberculosis ...
Journal Article
|
Research

Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age

Sauvageot D, Schaefer MM, Olson D, Pujades-Rodriguez M, O'Brien DP
2010-05-01 • BMC Pediatrics
2010-05-01 • BMC Pediatrics
OBJECTIVE: We describe medium-term outcomes for young children receiving antiretroviral therapy (ART) in resource-limited countries. METHODS: Analyses were conducted on surveillance data...
Journal Article
|
Research

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O,  et al.
2013-04-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
2013-04-15 • Journal of Acquired Immune Deficiency Syndromes (1999)
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness ...